Kimberly-Clark Corporation (KMB) financials

NASDAQ · Consumer Defensive · Household & Personal Products · 36,000 employees · CEO Michael D. Hsu

Price: $107.94 -1.89%
Market cap: $35.9B
Enterprise value: $41.5B
Last report: Q2 '26 filed 2026-08-04
Next report: 2026-11-05 EPS est. $1.65

Revenue (TTM)$16.6B-8.4% vs a year agoLast 4 quarters; bars = each quarter

Operating margin (TTM)12.4%-3.9 pp vs a year agoOperating income $2.05B

Net income (TTM)$1.96B-19.5% vs a year agoAfter tax, incl. non-operating gains

Free cash flow (TTM)$2.56B+21.8% vs a year agoCapex $772M

Diluted EPS (TTM)$5.88-19.0% vs a year agoSum of the last 4 quarters

Net cash-$5.56B+15.8% vs a year agoCash + short-term investments - debt

Valuation & key figures

Market cap: $35.9B
Revenue: $16.6B
Revenue growth: -4%
Profit margin: 11.8%
P/E: 18.4×
P/S: 2.2×
EV / EBITDA: 13.0×
Free cash flow: $2.56B
Net income: $1.96B
Revenue estimate: $16.6B
Earnings: 2026-11-05
Dividend: $5.10

Key takeaways

Computed from the reported numbers - every statement carries the figure it rests on.

Last report (2026-08-04): revenue missed by 0.8%, EPS missed by 10.4%Revenue $4.19B vs $4.22B expected (-0.8%); EPS $1.80 vs $2.01 (-10.4%).
Revenue growth accelerating: 0.6% year on yearQ2 '26 revenue $4.19B, against an average of -8.3% over the four quarters before.
Operating margin 12.4% (TTM), -3.9 pp on a year agoOperating income grew -30.1% while revenue grew -8.4%.
10.2% of pre-tax profit is non-operatingPre-tax income $2.29B vs operating income $2.05B (TTM). Gains on equity stakes and other one-off items lift net income and EPS - operating income is the cleaner measure of the business.
Capex 4.7% of revenue (a year ago 4.3%)$772M invested in the last 4 quarters (+0.3% on a year earlier). Free cash flow $2.56B = 131.0% of net income.
Returned $1.7B to shareholders = 66.4% of free cash flowBuybacks $21M (a year earlier $964M), dividends $1.68B, stock-based pay $131M (TTM).
Diluted share count up 0.0% in a year333M diluted shares in Q2 '26, 333M a year earlier.
Net debt $5.56BCash + short-term investments $956M, debt incl. leases $6.52B; a year ago net debt $6.61B.

Last quarter: Q2 '26

Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.

Quarter vs a year ago

	Q2 '26	Year ago	Change
Revenue	$4.19B	$4.16B	+0.6%
Gross margin	38.3%	35.0%	+3.3 pp
Operating income	$448M	$592M	-24.3%
Operating margin	10.7%	14.2%	-3.5 pp
Net income	$345M	$509M	-32.2%
Diluted EPS	$1.04	$1.53	-32.0%
Operating cash flow	$908M	$770M	+17.9%
Capex	$352M	$197M	+78.7%
Free cash flow	$556M	$573M	-3.0%
R&D	$0	$0	–
Stock-based compensation	$41M	$41M	0.0%

Reported vs consensus

2026-08-04

	Actual	Consensus	vs consensus
Revenue	$4.19B	$4.22B	-0.8%
EPS (as estimated)	$1.80	$2.01	-10.4%

From the report of 2026-08-04 for Q2 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.

EPS vs consensus

last 8 reports

Revenue

Where the money comes from - by business line and by region, quarter by quarter.

Revenue, operating income and growth

quarterly

Revenue by business line

stacked, quarterly

Segment	Q2 '26	y/y	Share	TTM	TTM y/y
International Personal Care (IPC)	–	–	–	–	–
Diapers	$1.75B	-0.9%	42.1%	$6.82B	–
Consumer tissue products	$1.02B	+1.8%	24.4%	$3.55B	–
International Family Care & Professional (IFP)	–	–	–	–	–
Away from Home Professional Products	$476M	+2.4%	11.4%	$1.62B	–
Adult care products	$493M	+0.2%	11.9%	$1.96B	–
Feminine care products	$423M	+2.7%	10.2%	$1.73B	–

Segment profits

Operating income per reported segment, read from the segment note of each 10-Q / 10-K (the profit split most data feeds leave out).

Segments in Q2 '26

Segment	Revenue	y/y	Operating income	y/y	Margin	Margin a year ago	TTM operating income
Personal Care	–	–	–	–	–	–	–
Consumer Tissue	–	–	–	–	–	–	–
KC Professional	–	–	–	–	–	–	–
Corporate And Other	–	–	–	–	–	–	–
North America NA	–	–	$725M	+10.7%	–	–	$2.57B
International Personal Care IPC	–	–	$186M	+2.2%	–	–	$844M
International Family Care Professional IFP	–	–	–	–	–	–	–
Corporate (unallocated)	–	–	-$278M	-13.5%	–	–	-$898M

Operating income by segment

quarterly

Segment operating margin

quarterly

Fourth quarters are derived: the 10-K reports the full year, minus the three quarters of the 10-Qs.

Margins & cost structure

How much of each unit of revenue is left at each level - and where the costs go.

Margins

quarterly

Costs as % of revenue

quarterly

Cash flow & capital allocation

Cash generated, what it is spent on, and what reaches shareholders.

Operating cash flow, capex, free cash flow

quarterly

Uses of cash vs operating cash flow

fiscal years

Last 4 quarters

cash flow statement

Operating cash flow: $3.33B
Capex: -$772M
Buybacks: -$21M
Dividends: -$1.68B
Acquisitions: $0
Net debt issued: $876M
Stock-based compensation: $131M
Free cash flow: $2.56B
Returned to shareholders / FCF: 66.4%

Share count and EPS

quarterly, diluted

Balance sheet

Liquidity, investments and debt at each quarter end.

Cash, investments and debt

quarter ends

Valuation & returns

Today's multiples against the company's own last five fiscal years; analyst targets and ratings.

Multiples and returns

TTM vs 5 fiscal years

	Now	5y average	Where today sits in the 5-year range
P/E (TTM)	18.4×	21.5×	16.6× – 26.6×
EV / EBITDA	13.0×	14.8×	12.2× – 17.4×
EV / Sales	2.5×	2.6×	2.3× – 2.9×
Price / FCF	14.0×	21.1×	14.8× – 28.0×
Price / Book	20.5×	59.5×	22.4× – 93.8×
FCF yield	7.1%	5.0%	3.6% – 6.7%
Return on invested capital	12.5%	19.2%	16.8% – 25.8%
Return on equity	122.6%	267.4%	134.6% – 353.6%

Analysts

Consensus target $114.20 (+5.8%)
range $105.00 – $120.00 · rating Hold

Strong buy0

Buy9

Hold20

Sell3

Strong sell0

Outlook

Analyst consensus for the coming fiscal years and what it implies at today's price.

Consensus estimates

Fiscal year	Revenue	Growth	EPS	Growth	P/E at today's price	Analysts (EPS)
FY2026	$16.6B	-3.5%	$7.39	+21.7%	14.6×	10
FY2027	$17B	+2.4%	$7.36	-0.3%	14.7×	7
FY2028	$17.4B	+2.5%	$7.91	+7.3%	13.7×	2
FY2029	$26.2B	+50.1%	$8.20	+3.8%	13.2×	1
FY2030	$35.8B	+36.9%	$8.79	+7.1%	12.3×	1

Financial statements

Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.

Income statementRevenue, costs, operating income, net income and EPSOpen Balance sheetCash, investments, assets, debt, liabilities and equityOpen Cash flowOperating cash flow, capex, free cash flow, buybacks and dividendsOpen

Every reported line

All 326 figures Kimberly-Clark Corporation tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).

Line (SEC label)	Latest quarter	Year ago	y/y	Latest FY	Prior FY	y/y
Accounts Payable, Current	$3.37B2026-06-30	$3.25B	+3.7%	$3.39B	$3.26B	+3.8%
Accounts Receivable, after Allowance for Credit Loss, Current	$1.86B2026-06-30	$2.01B	-7.4%	$1.89B	$1.73B	+9.5%
Accounts Receivable, Allowance for Credit Loss, Current	$45M2025-12-31	$48M	-6.3%	$45M	$48M	-6.3%
Accrued Advertising, Current	$459M2025-12-31	$486M	-5.6%	$459M	$486M	-5.6%
Accrued Liabilities, Current	$2.27B2026-06-30	$2.02B	+12.4%	$1.89B	$2.09B	-9.7%
Accrued Salaries, Current	$284M2025-12-31	$394M	-27.9%	$284M	$394M	-27.9%
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$9.89B2026-06-30	$9.76B	+1.4%	$9.73B	$9.42B	+3.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax	-$3.39B2026-06-30	-$3.51B	+3.5%	-$3.44B	-$3.77B	+8.6%
Additional Paid in Capital	$788M2026-06-30	$798M	-1.3%	$849M	$862M	-1.5%
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings	$426M2026-06-30	$418M	+1.9%	$1.71B	$1.67B	+2.0%
Advertising Expense	–	–	–	$1.02B	$1.12B	-9.1%
Amortization of Intangible Assets	–	–	–	$2M	$7M	-71.4%
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2.4M2026-06-30	1.1M	+118.2%	1.9M	1.2M	+58.3%
AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax	-$61M2025-09-30	-$95M	+35.8%	–	–	–
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	$39M2026-06-30	$39M	0.0%	$135M	$128M	+5.5%
Asset Impairment Charges	$18M2025-12-31	$0	–	$18M	$114M	-84.2%
Assets	$18.6B2026-06-30	$16.8B	+10.6%	$17.1B	$16.5B	+3.3%
Assets, Current	$6.35B2026-06-30	$5.56B	+14.3%	$5.31B	$5.58B	-4.8%
Buildings and Improvements, Gross	$2.38B2026-06-30	$2.39B	-0.7%	$2.35B	$2.31B	+1.7%
Capital Expenditure, Discontinued Operations	$67M2026-06-30	$21M	+219.0%	$118M	$116M	+1.7%
Cash and Cash Equivalents, at Carrying Value	$956M2026-06-30	$634M	+50.8%	$688M	$1.01B	-31.9%
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months	$3M2026-06-30	-$8M	+137.5%	-$21M	–	–
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$956M2026-06-30	$634M	+50.8%	$688M	$1.01B	-31.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations	$407M2026-06-30	$23M	+1,669.6%	$13M	$11M	+18.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$1.36B2026-06-30	$657M	+107.5%	$701M	$1.02B	-31.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$804M2026-06-30	$94M	+755.3%	-$320M	-$72M	-344.4%
Common Stock, Dividends, Per Share, Declared	$1.282026-06-30	$1.26	+1.6%	$5.04	$4.88	+3.3%
Common Stock, Par or Stated Value Per Share	$1.252026-06-30	$1.25	0.0%	$1.25	$1.25	0.0%
Common Stock, Shares Authorized	1.2B2026-06-30	1.2B	0.0%	1.2B	1.2B	0.0%
Common Stock, Shares, Issued	379M2026-06-30	379M	0.0%	379M	379M	0.0%
Common Stock, Shares, Outstanding	333M2026-06-30	332M	+0.2%	332M	332M	0.0%
Common Stock, Value, Issued	$473M2026-06-30	$473M	0.0%	$473M	$473M	0.0%
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest	$4M2026-06-30	$9M	-55.6%	$28M	$21M	+33.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$371M2026-06-30	$636M	-41.7%	$2.34B	$2.36B	-0.8%
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	$375M2026-06-30	$645M	-41.9%	$2.37B	$2.38B	-0.5%
Construction in Progress, Gross	$1.45B2026-06-30	$824M	+76.0%	$1.2B	$780M	+54.0%
Cost of Goods and Services Sold	$2.59B2026-06-30	$2.71B	-4.5%	$10.5B	$10.5B	+0.1%
Current Federal Tax Expense (Benefit)	–	–	–	$117M	$236M	-50.4%
Current Foreign Tax Expense (Benefit)	–	–	–	$226M	$195M	+15.9%
Current Income Tax Expense (Benefit)	–	–	–	$385M	$487M	-20.9%
Current State and Local Tax Expense (Benefit)	–	–	–	$42M	$56M	-25.0%
Debt, Current	$43M2026-06-30	$771M	-94.4%	$694M	$564M	+23.0%
Deferred Federal Income Tax Expense (Benefit)	–	–	–	$241M	-$14M	+1,821.4%
Deferred Foreign Income Tax Expense (Benefit)	–	–	–	-$28M	-$13M	-115.4%
Deferred Income Tax Expense (Benefit)	-$119M2026-06-30	-$37M	-221.6%	$241M	-$38M	+734.2%
Deferred Income Tax Liabilities, Net	$473M2026-06-30	$243M	+94.7%	$445M	$300M	+48.3%
Deferred State and Local Income Tax Expense (Benefit)	–	–	–	$1M	-$18M	+105.6%
Deferred Tax Assets, Gross	$1.62B2025-12-31	$1.54B	+4.9%	$1.62B	$1.54B	+4.9%
Deferred Tax Assets, Net of Valuation Allowance	$1.16B2025-12-31	$1.25B	-6.5%	$1.16B	$1.25B	-6.5%
Deferred Tax Assets, Other	$423M2025-12-31	$364M	+16.2%	$423M	$364M	+16.2%
Deferred Tax Assets, Other Tax Carryforwards	$712M2025-12-31	$623M	+14.3%	$712M	$623M	+14.3%
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits	$162M2025-12-31	$169M	-4.1%	$162M	$169M	-4.1%
Deferred Tax Assets, Valuation Allowance	$451M2025-12-31	$295M	+52.9%	$451M	$295M	+52.9%
Deferred Tax Liabilities, Goodwill	$69M2025-12-31	$64M	+7.8%	$69M	$64M	+7.8%
Deferred Tax Liabilities, Gross	$1.35B2025-12-31	$1.34B	+0.7%	$1.35B	$1.34B	+0.7%
Deferred Tax Liabilities, Leasing Arrangements	$109M2025-12-31	$105M	+3.8%	$109M	$105M	+3.8%
Deferred Tax Liabilities, Net	$184M2025-12-31	$94M	+95.7%	$184M	$94M	+95.7%
Deferred Tax Liabilities, Other	$186M2025-12-31	$203M	-8.4%	$186M	$203M	-8.4%
Deferred Tax Liabilities, Property, Plant and Equipment	$851M2025-12-31	$854M	-0.4%	$851M	$854M	-0.4%
Deferred Tax Liabilities, Undistributed Foreign Earnings	$133M2025-12-31	$113M	+17.7%	$133M	$113M	+17.7%

Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30

Data as of 2026-11-02